Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Minicam 20mg Tablet DT

Prescription Icon
Prescription Required

Marketer

Blue Cross Laboratories Ltd

Salt Composition

Piroxicam (20mg)

Overview Minicam 20mg Tablet DT

Diclofenac 20mg Delayed-Release Tablets offer pain relief for moderate to severe pain associated with conditions like osteoarthritis and rheumatoid arthritis. They alleviate joint and muscle pain and inflammation. For optimal absorption and reduced stomach upset, take these tablets with food. Dosage and treatment length vary depending on individual needs and response. Continue using the medication as directed by your physician, even if symptoms improve, until advised otherwise. Common side effects, such as nausea, vomiting, stomach pain, headache, and dizziness, are usually mild. Report persistent or worsening side effects to your doctor, who may offer management strategies. Prior to use, inform your physician of any history of stomach ulcers, heart conditions, hypertension, or liver/kidney disease. Similarly, disclose all other medications you are currently taking, as interactions are possible. Consult your doctor before using this medication if you are pregnant or breastfeeding.

Uses of Minicam 20mg Tablet DT

Alleviation of discomfort

Major Benefits of Minicam 20mg Tablet DT:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Minicam 20mg Tablet DT in water before consumption. It should be administered with a meal.

Common Side effects of Minicam 20mg Tablet DT:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Minicam 20mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Minicam 20mg Tablet DT in water before consumption. It should be taken with food.

How Minicam 20mg Tablet DT works:

Minicam 20mg Delayed-Release Tablets contain a non-steroidal anti-inflammatory agent that inhibits the production of inflammatory mediators, thus reducing pain and swelling.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Minicam 20mg DT tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Minicam 20mg Delayed-Release Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known risks. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Minicam 20mg Tablet DT while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Driving may be unsafe while taking Minicam 20mg DT Tablets due to potential drowsiness, dizziness, and visual disturbances. Avoid operating vehicles if you experience these side effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should use Minicam 20mg Tablet DT cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should use Minicam 20mg Tablet DT cautiously. Dosage modification for Minicam 20mg Tablet DT may be necessary. Physician consultation is advised.

What if you forget to take Minicam 20mg Tablet DT :

Should you forget to take a Minicam 20mg Tablet DT, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Minicam 20mg Tablet DT

LabelValue
Type of Compound Compounds derived from enolic acid
Potential for Dependence None.
Type of Medication Pain relievers

FAQs on Minicam 20mg Tablet DT

Minicam 20mg Tablet DT and diclofenac are analgesics. Piroxicam, the active ingredient in Minicam, non-selectively inhibits COX enzymes, which mediate inflammation and pain. Diclofenac exhibits greater selectivity for the COX-2 enzyme. This increased selectivity in diclofenac is believed to reduce the incidence of adverse effects relative to Minicam 20mg Tablet DT.
Minicam 20mg Tablet DT and naproxen are both analgesics, both non-selectively inhibiting COX enzymes—the enzymes mediating inflammation and pain sensation. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen demonstrates a lower incidence of gastrointestinal adverse effects relative to Minicam 20mg Tablet DT.
Minicam 20mg Tablet DT and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials demonstrate comparable efficacy for both drugs. Nevertheless, meloxicam exhibits a lower incidence of acute gastrointestinal adverse effects relative to Minicam 20mg Tablet DT.
Minicam 20mg Tablet DT and ketoprofen are both analgesic medications, both inhibiting cyclooxygenase (COX), the enzyme that mediates inflammation and pain. However, studies indicate superior efficacy and tolerability for topical ketoprofen gel relative to Minicam 20mg Tablet DT.
Minicam 20mg Delayed-Release Tablets target cyclooxygenase, an enzyme contributing to inflammation and pain. In contrast, Tramadol offers pain relief through a narcotic-like mechanism, and carries a risk of dependence.
Minicam 20mg Tablet DT and nimesulide are analgesics. Minicam 20mg Tablet DT broadly inhibits cyclooxygenase (COX), an enzyme mediating inflammation and pain, while nimesulide selectively targets COX-2. This selectivity in nimesulide is believed to reduce adverse reactions relative to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet levels. However, analgesics such as piroxicam increase the risk of bleeding. Therefore, avoid taking Minicam 20mg Tablet DT or other pain relievers for fever with joint pain. Always seek medical advice before commencing Minicam 20mg Tablet DT.
Minicam 20mg tablets and aspirin are distinct medications, although both are COX (cyclooxygenase) inhibitors, sharing anti-inflammatory and analgesic properties.
Concurrent use of Minicam 20mg Tablets and dexamethasone is contraindicated due to their synergistic toxicity, significantly raising the likelihood of gastrointestinal ulceration.
Indeed, concurrent use of methocarbamol and Minicam 20mg DT tablets is considered safe, lacking documented significant adverse interactions. However, physician consultation is advised prior to initiating either treatment.
Indeed, concurrent use of paracetamol and Minicam 20mg DT tablets is considered safe, lacking documented significant adverse interactions. However, physician consultation is advisable prior to initiating either treatment.
Minicam 20mg Tablet DT is indeed a non-steroidal anti-inflammatory drug.
Diclofenac 20mg extended-release tablets contain sulfur. This medication may trigger serious side effects in susceptible patients, including potentially life-threatening skin conditions such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Minicam 20mg DT tablets do not possess anticoagulant properties; they are analgesics. Patients with hemorrhagic conditions should refrain from using this medication.
Minicam 20mg tablets do not relax muscles. They are analgesics that inhibit COX enzymes, thereby reducing inflammation and pain.
Minicam 20mg Tablet DT is a non-narcotic analgesic. Its mechanism of action involves inhibiting COX enzymes, thereby reducing inflammation and pain.
Minicam 20mg Tablet DT does not treat high blood pressure. Concomitant use with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Minicam 20mg Tablet DT.
Concurrent use of Minicam 20mg Tablet DT and Losartan is contraindicated. Minicam 20mg Tablet DT reduces the efficacy of antihypertensive drugs such as Losartan, potentially rendering antihypertensive treatment ineffective. Patients using antihypertensive medications should disclose this to their physician prior to commencing Minicam 20mg Tablet DT.
Lisinopril and Minicam 20mg Tablet DT should not be used concurrently. Concomitant administration of piroxicam (the active ingredient in Minicam) and lisinopril reduces the antihypertensive effect of lisinopril, potentially compromising blood pressure control. Patients using antihypertensive drugs must disclose this to their physician prior to commencing Minicam 20mg Tablet DT treatment.
Indeed. Concurrent use of Minicam 20mg Delayed-Release Tablets and calcium channel blockers is acceptable. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may lessen the efficacy of most antihypertensive medications, with calcium channel blockers being a notable exception (White, 2007).
Tizanidine can be safely used concurrently with Minicam 20mg Delayed-Release Tablets. Piroxicam, an analgesic, and tizanidine, a muscle relaxant, are often combined to manage conditions such as back pain.
Affirmative. Concomitant administration of Minicam 20mg Tablet DT and beta-cyclodextrin is feasible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Indeed, Minicam 20mg Tablet DT has substitute medications. Analgesic selection depends on the specific illness. A physician's consultation is necessary prior to commencing piroxicam therapy or switching treatments.
Piroxicam should be avoided in patients with hypersensitivity, bleeding disorders, peptic or duodenal ulcers, mouth sores, systemic lupus erythematosus, inflammatory bowel disease, upper gastrointestinal problems, advanced pregnancy, heart conditions, liver dysfunction, or kidney impairment.
Minicam 20mg Tablet DT does not alleviate allergic reactions; it is an analgesic.
Piroxicam 20mg extended-release tablets provide sustained pain relief. Individual responses vary, with analgesic efficacy generally improving over several weeks of consistent use.
Minicam 20mg Tablets DT are not associated with hypertension. This medication is a non-opioid analgesic.
Minicam 20mg Delayed-Release tablets lack regulatory approval for managing dysmenorrhea. Clinical trials indicate that piroxicam demonstrates substantial efficacy in reducing menstrual pain.
Minicam 20mg Tablet DT lacks regulatory approval for migraine treatment. However, clinical trials indicate its efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, determining the underlying cause of your back pain requires a physician's evaluation prior to commencing treatment. Avoid self-treating with Minicam 20mg Tablet DT, as the etiology of back pain varies individually.
Acute gout can be treated with Minicam 20mg Tablet DT. Clinical trials demonstrate its high efficacy in managing acute gout flare-ups.
Blood donation is permissible while taking Minicam 20mg Tablet DT; however, it's crucial to disclose this medication use to your physician prior to donation.
Piroxicam (Minicam 20mg Tablet DT) should only be used by diabetic patients under strict medical supervision. Prolonged use of this medication carries a significant risk of kidney damage, a risk further elevated by the pre-existing renal complications often associated with diabetes. Therefore, piroxicam use in diabetic individuals substantially increases the likelihood of renal failure.
Individuals with impaired kidney function should avoid Minicam 20mg Tablets DT. Prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) is linked to kidney damage, including papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Minicam 20mg Tablet DT. These can include exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Such serious reactions may develop unexpectedly. Report any skin rash, even if mild, to your physician and stop taking the medication immediately.
Minicam 20mg Tablets (DT) are contraindicated during pregnancy. Their use is associated with premature ductus arteriosus closure, potentially resulting in fetal cardiac failure and infant mortality.
Minicam 20mg Tablet DT is not suitable for patients with active peptic ulcers. This medication has been associated with the development of gastric ulcers and bleeding.
Individuals with asthma may experience heightened sensitivity to nonsteroidal anti-inflammatory medications (NSAIDs), such as aspirin, potentially triggering severe asthma episodes. Seek medical advice prior to commencing treatment with such drugs.
Affirmative. The medication Minicam 20mg Tablet DT may induce temporary infertility in some cases. Piroxicam's mode of action can potentially hinder or inhibit the release of ovarian follicles, a factor linked to reversible infertility. Physician consultation is advised prior to commencing treatment.
Minicam 20mg Tablet DT is contraindicated for concurrent use with diuretics. In certain individuals, Minicam 20mg Tablet DT diminishes the sodium-excreting action of furosemide and thiazide diuretics. This effect is believed to result from the medication's suppression of renal prostaglandin production.
The concomitant use of Minicam 20mg Tablet DT and lithium is contraindicated. Minicam 20mg Tablet DT increases plasma lithium concentrations and decreases its renal clearance. This effect stems from the NSAID's inhibition of renal prostaglandin production. Physician consultation is mandatory prior to initiating Minicam 20mg Tablet DT therapy.
Concurrent use of Minicam 20mg Delayed-Release tablets and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before commencing Minicam therapy. Combined administration necessitates rigorous clinical monitoring.
Gastric ulcer risk rises with the use of medications such as corticosteroids and anticoagulants. Prolonged medication use, alcohol consumption, smoking, and advanced age are additional contributing factors to increased ulcer risk.
Individuals experiencing asthma, urticaria, or another allergic response to aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or pain medication immediately preceding or following coronary artery bypass grafting.
Gastrointestinal upset, and in infrequent cases, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; serious dermatological reactions including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic insufficiency; and kidney injury.
Minicam 20mg Tablet DT
23
MRP 28
17% off